Rigel Pharmaceuticals RIGL
NASDAQ RIGL
$46.97 -1.18 (-2.45%)
At close: Oct 1, 2026 · 4:00 PM EDT

Rigel Pharmaceuticals (RIGL) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Rigel Pharmaceuticals' Depreciation & Amortization (CF) came in at $848,000 for Q2 2026, up 39.7% from $607,000 a year earlier and up 42.0% from the prior quarter.

Analysis

Rigel Pharmaceuticals (RIGL) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Rigel Pharmaceuticals reported Depreciation & Amortization (CF) of $2.65 million, up 9.2% year-over-year; for FY2025, it was $2.42 million, up 8.4% from FY2024.

  • Depreciation & Amortization (CF) has increased in each of the last three years, with a five-year compound annual growth rate of 27.9% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $2.23 million in FY2024 (+80.0%), $1.24 million in FY2023 (+24.0%), $998,000 in FY2022 (-14.1%) and $1.16 million in FY2021 (+64.6%).
  • The Q2 2026 figure represents the highest quarterly Depreciation & Amortization (CF) in data going back to Q3 2010.
  • Year-over-year, Depreciation & Amortization (CF) increased in four of the last eight quarters, with growth averaging 37.8%.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q3 2024 (growth of 109.2%), and the weakest in Q4 2022 (a decline of 29.7%).
  • Business Quant data shows RIGL's Depreciation & Amortization (CF) at $597,000 (Q1 2026), $601,000 (Q4 2025) and $603,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Rigel Pharmaceuticals 899.44 Mn 365.32 Mn 70.18 Mn 848,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 848,000.00
Mar 31, 2026 597,000.00
Dec 31, 2025 601,000.00
Sep 30, 2025 603,000.00
Jun 30, 2025 607,000.00
Mar 31, 2025 604,000.00
Dec 31, 2024 604,000.00
Sep 30, 2024 611,000.00
Jun 30, 2024 613,000.00
Mar 31, 2024 400,000.00
Dec 31, 2023 293,000.00
Sep 30, 2023 292,000.00
Jun 30, 2023 296,000.00
Mar 31, 2023 357,000.00
Dec 31, 2022 284,000.00
Sep 30, 2022 240,000.00
Jun 30, 2022 237,000.00
Mar 31, 2022 237,000.00
Dec 31, 2021 404,000.00
Sep 30, 2021 261,000.00
API Access

Rigel Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=RIGL&period=max&api_key=YOUR_API_KEY